BioCryst Pharmaceuticals
BCRX
#5417
Rank
โ‚น127.29 B
Marketcap
โ‚น604.04
Share price
-7.11%
Change (1 day)
-8.31%
Change (1 year)

Market capitalization of BioCryst Pharmaceuticals (BCRX)

Market cap: โ‚น127.29 Billion

As of January 2026 BioCryst Pharmaceuticals has a market cap of โ‚น127.29 Billion. This makes BioCryst Pharmaceuticals the world's 5417th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioCryst Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น127.29 B-11.81%
2025โ‚น144.34 B5.36%
2024โ‚น137.00 B34.14%
2023โ‚น102.13 B-42.33%
2022โ‚น177.09 B-4.53%
2021โ‚น185.49 B92.82%
2020โ‚น96.20 B153.78%
2019โ‚น37.90 B-38.96%
2018โ‚น62.10 B101.31%
2017โ‚น30.85 B-2.76%
2016โ‚น31.72 B-36.93%
2015โ‚น50.30 B-9.28%
2014โ‚น55.45 B99.87%
2013โ‚น27.74 B601.19%
2012โ‚น3.95 B-33.02%
2011โ‚น5.90 B-43.28%
2010โ‚น10.41 B-20.86%
2009โ‚น13.16 B422.41%
2008โ‚น2.51 B-72.64%
2007โ‚น9.20 B-38.51%
2006โ‚น14.97 B-31.05%
2005โ‚น21.71 B298.75%
2004โ‚น5.44 B-2.28%
2003โ‚น5.57 B585.68%
2002โ‚น0.81 B-75.84%
2001โ‚น3.36 B-37.96%
2000โ‚น5.42 B-75.51%
1999โ‚น22.14 B397.23%
1998โ‚น4.45 B17.14%
1997โ‚น3.80 B-52.86%
1996โ‚น8.06 B

End of Day market cap according to different sources

On Jan 18th, 2026 the market cap of BioCryst Pharmaceuticals was reported to be:

โ‚น127.29 Billion
by Nasdaq info icon info icon
โ‚น127.29 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
โ‚น827.17 B 549.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น200.81 B 57.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น2.30 B-98.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น117.94 B-7.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น14.057 T 10,942.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น154.58 B 21.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น8.838 T 6,843.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
โ‚น53.17 B-58.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น3.92 B-96.91%๐Ÿ‡บ๐Ÿ‡ธ USA